Latest News

Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum

Everest Medicines (HKG: 01952) announced its interim results for the six months ended June 30, 2026. Everest delivered strong growth and reached an important profitability...

Is AI the new colonialism?

A Global South reckoning with the real cost of the AI boom Artificial Intelligence in the Global South: Power, Policy and Progress, a new book...

Popular:

TANAKA Invests in Clean Planet

To accelerate innovation in next-generation energy through collaboration in...

Asia’s fashion extravaganza CENTRESTAGE returns in September

- Record number of designer brands and fashion shows,...

Business

Events

Marketing

Technology

Medical